-
Seven lung cancer companies advancing new treatments in 2025
20 May 2025 13:28 GMT
… EGFR ex20ins inhibitor
Lead lung cancer candidate: Zipalertinib
Recent news … Jazz Pharmaceuticals’ lead lung cancer drug is called Zepzelca … with the anti-angiogenesis benefits of an … settings outside of lung cancer.
Lung cancer treatment market expected …
-
Quercetin and Nano-Derivatives: Potential and Challenges in Cancer Therapy
24 May 2025 12:50 GMT
… target EMT.84 In lung cancer, QUE inhibits metastasis … erlotinib.128
Inhibition of Angiogenesis
Angiogenesis plays a crucial role … translocation of β-catenin in lung cancer cell line. Nutr Cancer. … in non-small cell lung cancer. Biomed Pharmacother. 2023 …
-
Geriatric Nutritional Risk Index (GNRI) and Prognostic Nutritional Index (PNI) Before Treatment as the Predictive Indicators for Bone Metastasis in Prostate Cancer Patients
24 May 2025 12:50 GMT
… in men worldwide after lung cancer.2 Both the … , et al. Advanced lung cancer inflammation index combined with … endothelium crosstalk by fostering angiogenesis and activating immunoregulatory … for non-small cell lung cancer patients with bone metastasis …
-
Proteomic Characterization of Extracellular Vesicles from Human Neural Precursor Cells: A Promising Advanced Therapy for Neurodegenerative Diseases
24 May 2025 12:50 GMT
… attenuates apoptosis, inflammation, and promotes angiogenesis after spinal cord injury in … a novel serodiagnostic marker for lung cancer. Am J Pathol. 2018;188 …
-
Functionalized Boron Carbide Nanoparticles as Active Boron Delivery Agents Dedicated to Boron Neutron Capture Therapy
24 May 2025 00:50 GMT
… including increased proliferation, motility, angiogenesis, vascular mimicry, and invasiveness … , in mice with lung cancer and pulmonary metastases, slowing … cells to A549 lung cancer cells.35
The … Capture Therapy in the lung cancer treatment. Nanomedicine. …
-
HUTCHMED Highlights Clinical Data to be Presented at the 2025 ASCO Annual Meeting
23 May 2025 00:00 GMT
… -positive non-small cell lung cancer (“NSCLC”) with MET … LBA8505
Oral Abstract Session: Lung Cancer - Non-Small Cell … 8513
Rapid Oral Session: Lung Cancer - Non-Small Cell … appropriate therapeutic sequence with angiogenesis inhibitor and chemotherapy …
-
Exelixis Announces Encouraging Results from Phase 1b/2 STELLAR-002 Trial Evaluating Zanzalintinib in Combination with Immune Checkpoint Inhibitors in Advanced Kidney Cancer at ASCO 2025
22 May 2025 21:29 GMT
… and prostate cancers, followed by lung cancer and RCC. The most common … , hepatocellular carcinoma, non-small cell lung cancer, colorectal cancer and head and … such as oncogenesis, metastasis, tumor angiogenesis and resistance to multiple therapies …
-
Transarterial Chemoembolization, Molecular Targeted Treatments, and Programmed Death-(Ligand)1 Inhibitors, for Hepatocellular Carcinoma with Lung Metastasis: A Retrospective Cohort Study
22 May 2025 15:02 GMT
… of the maximum diameter of lung tumors was as follows: 61 patients … remodel the immune microenvironment, inhibit angiogenesis, and restore anti-tumor activity …
-
Metastatic Colorectal Cancer Pipeline Appears Robust With 150+ Key Pharma Companies Actively Working In The Therapeutics Segment | Delveinsight
22 May 2025 04:37 GMT
… or recurrent non-small cell lung cancer (NSCLC) and metastatic colorectal cancer … specifically, which then inhibits tumour angiogenesis and thus suppressing the growth … have been implicated in pathogenic angiogenesis, tumor growth, and cancer progression …
-
Combination of Hepatic Arterial Infusion Chemotherapy with Tyrosine Kinase Inhibitor Provides Better Survival in Advanced Hepatocellular Carcinoma Patients
21 May 2025 11:46 GMT
… /ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis … producing human small cell lung cancer H146, based on angiogenesis inhibition. Int J …
About
© 1995-2025